Cost Information on Carpal Tunnel Syndrome Treatment Decisions
Does Societal Cost Information Affect Patient Decision-Making in Carpal Tunnel Syndrome: A Randomized Controlled Trial
1 other identifier
interventional
184
1 country
6
Brief Summary
The purpose of this study was to determine whether the provision of societal cost information affects patients' decisions whether or not to undergo surgical management in carpal tunnel syndrome, using a hypothetical scenario.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2018
CompletedFirst Submitted
Initial submission to the registry
March 13, 2019
CompletedFirst Posted
Study publicly available on registry
March 19, 2019
CompletedMarch 19, 2019
March 1, 2019
3 months
March 13, 2019
March 18, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants choosing carpal tunnel release or splinting
Choice for carpal tunnel release over splinting. All participants were presented a hypothetical case of mild carpal tunnel syndrome. The scenario described (nocturnal) symptoms of numbness and tingling and two treatment choices: carpal tunnel release or wrist splinting. In addition, participants were randomized to review total annual societal cost information for CTR procedures in the United States. After reviewing the case, participants were asked to indicate if they would choose surgery (more expensive) or splinting (less expensive). Scoring was measured on a 6-point ordinal Likert scale (ranging from 1="Definitely not" to 6="Definitely").
Immediately after reading the hypothetical scenario
Study Arms (2)
Cost group
EXPERIMENTALThese patients reviewed total societal costs associated with carpal tunnel release.
No cost group
NO INTERVENTIONThese patients did not review total societal costs associated with carpal tunnel release.
Interventions
Annual societal cost information to the US for carpal tunnel release surgery was displayed.
Eligibility Criteria
You may qualify if:
- English speaking upper extremity patients
- Nontraumatic condition
You may not qualify if:
- Traumatic condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Texas at Austinlead
- Stanford Universitycollaborator
Study Sites (6)
Austin Regional Clinic
Austin, Texas, 78705, United States
Texas Orthopedics
Austin, Texas, 78705, United States
HTB Musculoskeletal Institute
Austin, Texas, 78712, United States
Seton Institute for Plastic and Reconstructive Surgery
Austin, Texas, 78731, United States
Orthopedic Specialists of Austin
Austin, Texas, 78751, United States
ATX Ortho
Austin, Texas, 78756, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Dean for Comprehensive Care and Professor, Department of Surgery and Perioperative Care
Study Record Dates
First Submitted
March 13, 2019
First Posted
March 19, 2019
Study Start
September 24, 2018
Primary Completion
December 26, 2018
Study Completion
December 26, 2018
Last Updated
March 19, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share